Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
375 studies found for:    Open Studies | "Arthritis, Rheumatoid"
Show Display Options
Rank Status Study
21 Recruiting A Multicenter, 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: Acthar;   Drug: Placebo
22 Recruiting Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab
Condition: Arthritis, Rheumatoid
Interventions: Drug: ABP 710;   Drug: Infliximab
23 Recruiting Study to Assess if ABP798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Rituximab
Condition: Arthritis, Rheumatoid
Interventions: Drug: ABP 798;   Drug: Rituximab
24 Recruiting A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Condition: Arthritis, Rheumatoid
Interventions: Drug: LBAL;   Drug: Humira®
25 Not yet recruiting An Evaluation of the Safety of Escalating Doses of Tc 99m Tilmanocept by Intravenous (IV) Injection and Skeletal Joint Imaging With SPECT in Subjects With Active Rheumatoid Arthritis (RA) and Healthy Controls
Condition: Arthritis, Rheumatoid
Interventions: Drug: Tc99m tilmanocept;   Procedure: 30 Minutes post-injection whole body planar SPECT imaging with 3D SPECT or SPECT/CT for targeted joints of interest;   Procedure: 90 Minutes post-injection whole body planar SPECT imaging with 3D SPECT or SPECT/CT for targeted joints of interest;   Procedure: 180 Minutes post-injection whole body planar SPECT imaging with 3D SPECT or SPECT/CT for targeted joints of interest
26 Recruiting Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe
Condition: Arthritis, Rheumatoid
Intervention: Drug: Methotrexate
27 Recruiting Screening Protein Markers in Patients With Rheumatoid Arthritis and Hot-dampness and Blood Stasis Syndrome
Condition: Arthritis, Rheumatoid
Intervention:
28 Recruiting Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Iguratimod
29 Recruiting A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques
Condition: Arthritis, Rheumatoid
Interventions: Other: Gadobutrol;   Other: 18F-FDG;   Other: 18F-GE-180
30 Recruiting Discovering the Antecedents of Rheumatoid Arthritis Flare
Condition: Rheumatoid Arthritis
Intervention:
31 Recruiting Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: tofacitinib;   Biological: adalimumab;   Biological: etanercept
32 Recruiting The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Dietary Supplement: Protein;   Dietary Supplement: Carbohydrate (Placebo);   Other: Resistance Exercise Program
33 Recruiting Rheumatoid Arthritis Patients and Porphyromonas Gingivalis
Condition: Rheumatoid Arthritis
Interventions: Procedure: blood sample;   Procedure: synovial tissue
34 Not yet recruiting Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?
Conditions: Arthritis, Rheumatoid;   Atherosclerosis
Interventions: Drug: Sildenafil;   Other: Placebo
35 Recruiting Reduced Ultrasound Counts in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
36 Recruiting ACTH Gel Therapy in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: ACTHAR gel
37 Recruiting Pragmatic Study Comparing the Clinical Evlauation Methods ( C) and / or Ultrasound Method ( B or D) in Rheumatoid Arthritis to Adapt Treatment
Condition: Rheumatoid Arthritis
Interventions: Device: Xrays;   Device: Ultrasound (B mode );   Device: Ultrasound (D mode)
38 Recruiting Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Interventions: Biological: CFZ533;   Drug: Placebo
39 Recruiting Incorporation of Patient Reported Outcomes Data in the Care of US Veterans With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Other: PRO data utilized;   Other: PRO data not utilized
40 Recruiting A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics
Condition: Rheumatoid Arthritis
Interventions: Drug: E6011;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.